+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antiemetic Drugs - Market Analysis, Trends, and Forecasts

  • ID: 4805108
  • Report
  • 94 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Baxter International
  • Cipla
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • MORE
Antiemetic Drugs market worldwide is projected to grow by US$2.2 Billion, driven by a compounded growth of 6.2%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$101.2 Million to the region's size and clout in the next 5 to 6 years. Over US$325.9 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Chemotherapy will reach a market size of US$258.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$381.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include the following, among others:
  • Abbott Laboratories, Inc. (USA)
  • Astellas Pharma, Inc. (Japan)
  • Baxter International, Inc. (USA)
  • Cipla Ltd. (India)
  • GlaxoSmithKline PLC (United Kingdom)
  • Johnson & Johnson (USA)
  • Merck & Co., Inc. (USA)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (USA)
  • Sanofi-aventis U.S. LLC (USA)
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Baxter International
  • Cipla
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Antiemetic Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Antiemetic Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Antiemetic Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Antiemetic Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Chemotherapy (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 5: Chemotherapy (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 6: Chemotherapy (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Gastroenteritis (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025

TABLE 8: Gastroenteritis (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017

TABLE 9: Gastroenteritis (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

TABLE 10: Surgery (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 11: Surgery (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017

TABLE 12: Surgery (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025

TABLE 14: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 15: Other Applications (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Antiemetic Drugs Market Share (in %) by Company: 2019 & 2025

TABLE 16: United States Antiemetic Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 17: Antiemetic Drugs Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017

TABLE 18: Antiemetic Drugs Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025

CANADA

TABLE 19: Canadian Antiemetic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 20: Antiemetic Drugs Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 21: Canadian Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025

JAPAN

TABLE 22: Japanese Demand Estimates and Forecasts for Antiemetic Drugs in US$ Million by Application: 2018 to 2025

TABLE 23: Japanese Antiemetic Drugs Market in US$ Million by Application: 2009-2017

TABLE 24: Antiemetic Drugs Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025

CHINA

TABLE 25: Chinese Demand for Antiemetic Drugs in US$ Million by Application: 2018 to 2025

TABLE 26: Antiemetic Drugs Market Review in China in US$ Million by Application: 2009-2017

TABLE 27: Chinese Antiemetic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European Antiemetic Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 28: European Antiemetic Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 29: Antiemetic Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 30: European Antiemetic Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 31: European Antiemetic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 32: Antiemetic Drugs Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 33: European Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025

FRANCE

TABLE 34: Antiemetic Drugs Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025

TABLE 35: French Antiemetic Drugs Historic Market Review in US$ Million by Application: 2009-2017

TABLE 36: French Antiemetic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

GERMANY

TABLE 37: Antiemetic Drugs Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 38: German Antiemetic Drugs Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 39: Antiemetic Drugs Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025

ITALY

TABLE 40: Italian Demand for Antiemetic Drugs in US$ Million by Application: 2018 to 2025

TABLE 41: Antiemetic Drugs Market Review in Italy in US$ Million by Application: 2009-2017

TABLE 42: Italian Antiemetic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 43: United Kingdom Demand Estimates and Forecasts for Antiemetic Drugs in US$ Million by Application: 2018 to 2025

TABLE 44: United Kingdom Antiemetic Drugs Market in US$ Million by Application: 2009-2017

TABLE 45: Antiemetic Drugs Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 46: Rest of Europe Antiemetic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 47: Antiemetic Drugs Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 48: Rest of Europe Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 49: Antiemetic Drugs Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025

TABLE 50: Asia-Pacific Antiemetic Drugs Historic Market Review in US$ Million by Application: 2009-2017

TABLE 51: Asia-Pacific Antiemetic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

REST OF WORLD

TABLE 52: Rest of World Antiemetic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 53: Antiemetic Drugs Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 54: Rest of World Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT LABORATORIES

ASTELLAS PHARMA

BAXTER INTERNATIONAL

CIPLA

GLAXOSMITHKLINE PLC

JOHNSON & JOHNSON

MERCK & CO., INC.

NOVARTIS AG

PFIZER

SANOFI-AVENTIS US

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Astellas Pharma
  • Baxter International
  • Cipla
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis Ag
  • Pfizer
  • Sanofi-Aventis Us
Note: Product cover images may vary from those shown
Adroll
adroll